Synapse Biomedical Inc.

Synapse Biomedical Inc. is an FDA-approved medical device company specializing in neurostimulation products for treating chronic respiratory insufficiency. Founded in 2002 and based in Oberlin, Ohio, the company develops minimally invasive diaphragm pacing systems designed to reduce mechanical ventilator dependence in patients with spinal cord injuries, amyotrophic lateral sclerosis (ALS), and other neurological conditions. The company's flagship product, the NeuRx® Diaphragm Pacing System (DPS), electrically stimulates the diaphragm to assist ventilation and restore respiratory muscle function. With over 2,000 patients successfully treated and coverage by Medicare, Medicaid, and private insurance, Synapse continues to advance respiratory care standards. The company also offers the TransAeris® system for preventing ventilator-induced diaphragm dysfunction (VIDD) in critically ill patients requiring temporary stimulation.